EUROPEAN MOLECULAR BIOLOGY ORGANIZATION

Their core work

EMBO is a Geneva-based pan-European membership organization that supports excellence in life sciences by funding fellowships, running training courses, organising workshops, and publishing scientific journals. In H2020, they participated as a supporting partner rather than a research executor — contributing their established infrastructure for scientific training and their network for international coordination. Their value to consortia lies not in running experiments but in providing credibility, dissemination reach, and training programme design to research networks across Europe and beyond.

What they specialise in

How they've shifted over time

In the earlier ChromDesign project (2018–2023), EMBO's contribution centred on training, imaging, and genomics — areas tightly aligned with their traditional role as an organiser of advanced courses for molecular biologists. The BioRoboost project (2018–2021) shows a complementary strand: standards-setting and international coordination in synthetic biology. With only two projects and both starting in 2018, there is no meaningful temporal shift to observe — these were parallel commitments rather than a sequential evolution of focus.

EMBO appears to be extending its coordination role beyond classical molecular biology into emerging fields like synthetic biology, where international standardisation is an open problem and their organisational authority carries weight.

How they like to work

EMBO never led an H2020 project — they joined as partner or third party in both cases, which is consistent with their identity as a supporting infrastructure organisation rather than a primary research executor. Both projects involved large, multinational consortia (41 unique partners across 17 countries combined), suggesting EMBO is deliberately chosen for its convening power and European reach rather than for running experiments. Collaborating with EMBO typically means gaining access to their training infrastructure, journal network, and scientific community — not a technical co-investigator.

Despite only two projects, EMBO touched 41 unique consortium partners spread across 17 countries — an unusually broad network footprint per project, reflecting the large international consortia they join. Their reach is genuinely global, not merely European, given their membership base extends to scientists worldwide.

What sets them apart

EMBO is one of very few organisations in Europe that combines scientific credibility, a large active membership of working researchers, and an established training and publishing infrastructure — all without being a university or research institute. For a consortium that needs a high-profile dissemination or training partner with instant recognition across European research institutions, EMBO provides that without the administrative weight of a large university. Their distinctiveness is organisational authority and network density, not laboratory capacity.

Highlights from their portfolio

• ChromDesign
  A long-running MSCA training network (2018–2023) in 3D genomics and chromatin architecture — a field that has grown in strategic importance with the rise of spatial biology and gene regulation research.
• BioRoboost
  A coordination action on synthetic biology standardisation — notable because it shows EMBO operating at the policy and standards layer, not just the research layer, which is a less common role for scientific membership organisations.